Abstract
Fibrin formation and removal occurs continuously during the development of malignancy. Accordingly, hemostatic disorders in cancer patients are a rather frequent observation and range from asymptomatic laboratory changes to massive thromboembolism or haemorrhage. We document the case of an asymptomatic women, who was enrolled as a healthy control in a study and showed up with a substantially increased D-dimer value. After ruling out the most probable sources of D-dimer elevation, such as thrombosis, inflammation and trauma, she underwent laboratory and radiological investigations for malignancy, which were consistent with a colorectal metastatic adenocarcinoma. This case allow us to hypothesize that screening for occult malignancy in the presence of apparently inexplicable elevated D-dimer values may be taken into considerationReferences
- Piccioli A, Falanga A, Baccaglini U, Marchetti M, Prandoni P. Cancer and venous thromboembolism. Semin Thromb Hemost. 2006; 32:694-9. Google Scholar
- Rak J, Yu JL, Luyendyk J, Mackman N. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res. 2006; 66:10643-6. Google Scholar
- Garcia-Avello A, Galindo-Alvarez J, Martinez-Molina E, Cesar-Perez J, Navarro JL. Coagulative system activation and fibrinolytic system inhibition activities arise from tumoral draining vein in colon carcinoma. Thromb Res. 2001; 104:421-5. Google Scholar
- Ozturk M, Sengul N, Dagli M, Kosar A, Bavbek N. Global fibrinolytic capacity in colorectal cancer: a new clue to occult fibrinolysis. Clin Appl Thromb Hemost. 2003; 9:151-4. Google Scholar
- Falanga A, Marchetti M, Vignoli A, Balducci D. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression. Clin Adv Hematol Oncol. 2003; 1:673-8. Google Scholar
- Falanga A. Thrombophilia in cancer. Semin Thromb Hemost. 2005; 31:104-10. Google Scholar
- Rege KP, Jones S, Day J, Hoggarth CE. In proven deep vein thrombosis, a low positive D-Dimer score is a strong negative predictor for associated malignancy. Thromb Haemost. 2004; 91:1219-22. Google Scholar
- Paneesha S, Cheyne E, French K, Bacchu S, Borg A, Rose P. High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes. Br J Haematol. 2006; 135:85-90. Google Scholar
- Oya M, Akiyama Y, Yanagida T, Akao S, Ishikawa H. Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker. Surg Today. 1998; 28:373-8. Google Scholar
- Oya M, Akiyama Y, Okuyama T, Ishikawa H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001; 31:388-94. Google Scholar
- Xu G, Zhang YL, Huang W. Relationship between plasma D-dimer levels and clinicopathologic parameters in resectable colorectal cancer patients. World J Gastroenterol. 2004; 10:922-3. Google Scholar
- Paneesha S, Cheyne E, French K, Delgado J, Borg A, Rose P. High D-dimer level at presentation in patients with venous thrombosis is a marker for malignancy. Haematologica. 2005; 90:ELT08. Google Scholar
- Falanga A. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis. Haematologica. 2005; 90:149. Google Scholar
- Schutgens RE, Beckers MM, Haas FJ, Biesma DH. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis. Haematologica. 2005; 90:214-9. Google Scholar
- Gouin-Thibault I, Achkar A, Samama MM. The thrombophilic state in cancer patients. Acta Haematol. 2001; 106:33-42. Google Scholar
- Orlay G. Haemorrhoids - A review. Aust Fam Physician. 2003; 32:523-6. Google Scholar
- Lee AY. Thrombosis and cancer: the role of screening for occult cancer and recognizing the underlying biological mechanisms. Hematology Am Soc Hematol Educ Program. 2006;438-43. Google Scholar
- Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol. 2005; 6:401-10. Google Scholar
- Kockar C, Kockar O, Ozturk M, Dagli M, Bavbek N, Kosar A. Global fibrinolytic capacity increased exponentially in metastatic colorectal cancer. Clin Appl Thromb Hemost. 2005; 11:227-30. Google Scholar
- Kazmierczak M, Lewandowski K, Wojtukiewicz MZ, Turowiecka Z, Kolacz E, Lojko A. Cancer procoagulant in patients with adenocarcinomas. Blood Coagul Fibrinolysis. 2005; 16:543-7. Google Scholar